Identification and biological activity of tamoxifen metabolites in human serum.


During the examination of serum samples from patients on chronic 'Nolvadex' therapy three major metabolites (X, Y and Z) were detected in addition to the parent drug. Two of these metabolites have been positively identified as N-desmethyltamoxifen (X) and a side-chain primary alcohol (Y). The third metabolite (Z) has been tentatively identified as N-desdimethyltamoxifen. Quantitative analysis of these metabolites in sera from patients undergoing chronic Nolvadex therapy (20 mg approximately b.d.) has shown that the mean N-desmethyltamoxifen concentration was 481 ng/ml, the mean metabolite Y concentration was 49 ng/ml and that desdimethyltamoxifen concentrations were in the range 20-40 ng/ml. The corresponding mean unchanged drug level in these patients was 310 ng/ml. 4-Hydroxytamoxifen could not be detected in these samples. Measurements of the relative binding affinities of tamoxifen and its metabolites for rat uterus oestrogen receptors have shown that 4-hydroxytamoxifen had a relative binding affinity similar to oestradiol while tamoxifen and its side-chain metabolites had lower affinities. It has been shown that all the metabolites examined are antioestrogenic, as demonstrated by their ability to prevent implantation in pregnant rats and inhibit oestradiol-induced uterine weight gain. It is therefore possible that the metabolites of tamoxifen collectively contribute to the therapeutic activity of the drug.

Citations per Year

353 Citations

Semantic Scholar estimates that this publication has 353 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Kemp1983IdentificationAB, title={Identification and biological activity of tamoxifen metabolites in human serum.}, author={John V Kemp and H. K. Adam and Alan E. Wakeling and Rosalyn Slater}, journal={Biochemical pharmacology}, year={1983}, volume={32 13}, pages={2045-52} }